zetidoline has been researched along with Basal Ganglia Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubini, A; Freeman, HL; Levine, S; Silverstone, T | 1 |
1 trial(s) available for zetidoline and Basal Ganglia Diseases
| Article | Year |
|---|---|
Zetidoline, a new antipsychotic. First controlled trial in acute schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Double-Blind Method; Female; Haloperidol; Humans; Imidazoles; Male; Middle Aged; Schizophrenia | 1984 |